About Octarine

Octarine Bio is a synthetic biology company based in Copenhagen, Denmark, founded in 2018. The company focuses on developing bio-based, low-impact solutions to address significant environmental challenges. It leverages foundational research from esteemed institutions, including the University of Copenhagen and the Technical University of Denmark. The company specializes in creating sustainable products through precision fermentation and enzymatic enhancement. Their offerings include natural, non-GMO textile dyes, with their flagship product PurePalette™ serving as a sustainable alternative to synthetic dyes. Additionally, Octarine Bio produces natural ingredients for skincare and health supplements, enhancing bioavailability and stability. They also develop novel cannabinoids and bioactive tryptamines aimed at improving human and planetary health. Octarine Bio operates primarily on a B2B model, targeting businesses in the textile, skincare, and health supplement sectors. With a total funding of €12 million as of November 2023, Octarine Bio is supported by various investors and is focused on scaling production and commercialization efforts. The company is led by CEO Nethaji Gallage and fosters a culture of innovation and sustainability within its diverse team.